News
The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...
1d
Pharmaceutical Technology on MSNNovo Nordisk defeated in Wegovy patent dispute by ViatrisThe Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...
The SELECT trial demonstrated a clear cardiovascular protection associated with semaglutide use, which could explain its ...
If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...
Semaglutide, a GLP-1R agonist developed by Denmark’s Novo Nordisk as Ozempic, initially for type 2 diabetes, and marketed ...
People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...
Medically reviewed by Mary Choy, PharmD The Food and Drug Administration (FDA) has approved both Ozempic and Wegovy (semaglutide) to lower blood sugar, improve heart health, and support weight loss.
India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...
You’ve probably heard a lot about Ozempic and Wegovy, the semaglutide wonder drugs for weight loss.Their newfound popularity with prescribers and online pharmacies has sparked a global shortage. ...
Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results